A detailed history of Portland Investment Counsel Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Portland Investment Counsel Inc. holds 324 shares of REGN stock, worth $227,399. This represents 0.14% of its overall portfolio holdings.

Number of Shares
324
Previous 324 -0.0%
Holding current value
$227,399
Previous $340,000 -0.0%
% of portfolio
0.14%
Previous 0.13%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$883.2 - $1071.19 $2,649 - $3,213
-3 Reduced 0.92%
324 $340,000
Q3 2023

Nov 13, 2023

SELL
$692.45 - $844.37 $2,077 - $2,533
-3 Reduced 0.91%
327 $269,000
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $189,410 - $239,025
330 New
330 $227,000
Q2 2022

Aug 12, 2022

SELL
$548.35 - $738.84 $180,955 - $243,817
-330 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$595.12 - $698.43 $595 - $698
1 Added 0.3%
330 $230,000
Q4 2021

Feb 14, 2022

BUY
$543.48 - $670.97 $178,804 - $220,749
329 New
329 $208,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Portland Investment Counsel Inc. Portfolio

Follow Portland Investment Counsel Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portland Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Portland Investment Counsel Inc. with notifications on news.